Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NewGenIvf GroupNIVF -9.09%14 EPS without NRI is $1,311.17 as of Dec. 2025. GuruFocus rates NIVF with a GF Score™ of 14/100. The stock has 4 warning signs investors should review. Among 509 Healthcare Providers & Services companies, NewGenIvf Group ranks worse than 196463.46% on this metric.
NewGenIvf Group's earnings per share without non-recurring items for the
three
months ended in Dec. 2025 was $-95.59.
Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was $1,311.17.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.
The historical rank and industry rank for NewGenIvf Group's EPS without NRI or its related term are showing as below:
During the past 5 years, NewGenIvf Group's highest 3-Year average Earnings Per Share (NRI) Growth Rate was -659.10% per year. The lowest was -659.10% per year. And the median was -659.10% per year.
NIVF's 3-Year EPS without NRI Growth Rate is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 11.5 * Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
NewGenIvf Group's EPS (Diluted) for the
three
months ended in Dec. 2025 was $-95.59.
Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $1,311.17.
NewGenIvf Group's EPS (Basic) for the
three
months ended in Dec. 2025 was $-95.59.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was $1,311.17.
NewGenIvf Group (NAS:NIVF) EPS without NRI Explanation
EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
NewGenIvf Group EPS without NRI Related Terms
NewGenIvf Group EPS without NRI Historical Data
* Premium members only.
The historical data trend for NewGenIvf Group's EPS without NRI can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NIVF vs RHEP, XCRT, SYRA: EPS without NRI Comparison
For the Medical Care Facilities subindustry, NewGenIvf Group's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NewGenIvf Group PE Ratio without NRI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, NewGenIvf Group's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where NewGenIvf Group's PE Ratio without NRI falls into.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.
EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,311.17
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NewGenIvf Group (NIVF) has a EPS without NRI of $1,311.17 as of Dec. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on NewGenIvf Group and its competitors. According to the industry distribution chart, NewGenIvf Group ranks #999999 out of 509 companies in the Healthcare Providers & Services industry.
Is NewGenIvf Group's EPS without NRI too high?
NewGenIvf Group's current EPS without NRI is $1,311.17. The Healthcare Providers & Services industry median EPS without NRI is 11.50. NewGenIvf Group's value of $1,311.17 is 11301.5% above this industry median. Based on the distribution chart, NewGenIvf Group ranks #999999 out of 509 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, NewGenIvf Group has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does NewGenIvf Group's EPS without NRI compare to RHEP and XCRT?
According to the Healthcare Providers & Services industry distribution chart, NewGenIvf Group ranks #999999 out of 509 companies for EPS without NRI. This places NewGenIvf Group in the lower half of its industry. The industry median EPS without NRI is 11.50. NewGenIvf Group's value of $1,311.17 is 11301.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Healthcare Providers & Services company?
The median EPS without NRI among Healthcare Providers & Services companies is 11.50, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NewGenIvf Group's current EPS without NRI of $1,311.17 is 11301.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on NewGenIvf Group and its competitors. For the Healthcare Providers & Services industry, the median EPS without NRI is 11.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NewGenIvf Group's current EPS without NRI is $1,311.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NewGenIvf Group stock overvalued right now?
NewGenIvf Group (NIVF) has a current EPS without NRI of $1,311.17. The current EPS without NRI is $1,311.17 and 11301.5% above the Healthcare Providers & Services industry median of 11.50. NewGenIvf Group's overall GF Score™ is 14/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For NewGenIvf Group (NIVF), the current EPS without NRI is $1,311.17 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
NewGenIvf Group Ltd is a tech-forward, diversified, multi-jurisdictional entity capitalizing on emerging opportunities across real estate development, digital asset innovation, and reproductive health solutions. The company offers two services, namely: in vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and fertility referral services, like surrogacy and ancillary caring services. It derives maximum revenue from in vitro fertilization (IVF) treatment service. Its Geographical presence is in China / HK SAR, Thailand, Cambodia, U.S and Kyrgyzstan. The company derives maximum revenue from Kyrgyzstan.
14GF Score
Get the complete analysis for NIVF
EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NIVF has been successfully added to your 
